ClinCalc Pro
Menu
Calculators Drugs Pathways AI Dx Donate Get the App
Topical macrolide antibiotic (anti-acne) Pregnancy: Compatible — topical erythromycin is considered safe in pregnancy for acne management.

Erythromycin 2% Topical

Brand names: Stiemycin (2% solution), Zineryt (erythromycin 4% + zinc acetate 1.2%)

Adult dose

Dose: Apply twice daily to affected areas
Route: Topical (solution, gel, or lotion)
Frequency: Twice daily (morning and evening)
Max: Apply to affected areas only — avoid large surface areas
For mild-moderate inflammatory acne. Stiemycin 2% solution: apply to clean, dry skin twice daily. Zineryt (erythromycin + zinc acetate): zinc reduces antibiotic resistance and has anti-inflammatory effect. Use for minimum 6–8 weeks. Combine with benzoyl peroxide to limit resistance.

Paediatric dose

Route: Topical
Frequency: Twice daily
Max: Apply to affected areas only
Concentration: 2% solution or 4%/1.2% (Zineryt) Application/ml
Licensed for use in children ≥12 years for acne. Avoid in younger children unless under specialist guidance.

Dose adjustments

Renal

N/A — topical use, minimal systemic absorption.

Hepatic

N/A — topical use.

Clinical pearls

  • Antibiotic resistance is the major concern with topical erythromycin monotherapy — always combine with benzoyl peroxide (Zineryt already contains zinc which reduces resistance)
  • Zineryt (erythromycin + zinc) preferred over plain erythromycin solution — zinc reduces resistance and has anti-inflammatory and sebosuppressive effects
  • Topical erythromycin is preferred over oral in pregnancy for acne (safe topical antibiotic option)
  • BAD guidelines: do not use topical antibiotics alone — always combine with benzoyl peroxide or retinoid
  • Avoid concurrent oral antibiotics of different class — no added benefit and increases resistance pressure

Contraindications

  • Hypersensitivity to erythromycin or macrolides
  • Application to broken skin, eyes, or mucous membranes

Side effects

  • Local skin dryness and irritation
  • Erythema at application site
  • Antibiotic resistance (C. acnes) — significant concern with prolonged monotherapy

Interactions

  • No significant systemic interactions at topical doses
  • Concurrent oral macrolides — theoretical additive resistance pressure

Monitoring

  • Acne response at 6–8 weeks
  • Signs of antibiotic resistance (treatment failure)
  • Local skin tolerance

Reference: BNFc; BNF; BAD Acne Guidelines 2021; NICE CG184. Verify against your local formulary and the latest BNF before prescribing.

Related

Curated clinical cross-links plus same-class fallbacks.

Calculators
Pathways